LunarCrush LLM | creator/twitter::1249712127646093313/posts

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@GolfNut48846224](/creator/twitter/GolfNut48846224)
"@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY"  
[X Link](https://x.com/GolfNut48846224/status/1972606560410165362) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-29T10:17Z XXX followers, 1362 engagements


"@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF"  
[X Link](https://x.com/GolfNut48846224/status/1972948354314465434) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-30T08:55Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@GolfNut48846224 "@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY"
X Link @GolfNut48846224 2025-09-29T10:17Z XXX followers, 1362 engagements

"@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF"
X Link @GolfNut48846224 2025-09-30T08:55Z XXX followers, XXX engagements